As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
In the press release of September 3, 2018, Europlasma (the "Company") announced the suspension of the exercise of the third warrant given access to convertible bonds ("OCA") relating to the contract signed on July 17, 2018 (renewal of the contract concluded on February 9, 2018) with the Luxembourg fund European High Growth Opportunities Securitization Fund (the "Investor").
